Gregory Cheng

Use of convalescent plasma therapy in SARS patients in Hong Kong

Yi‐Chang Cheng, Raymond Wong, Y.O.Y. Soo et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2004 · 1K citations

Life Sciences, Immunology, Pharmacotherapy +5

Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

James B. Bussel, Gregory Cheng, Mansoor N. Saleh et al. · New England Journal of Medicine · 2007 · 805 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score

Dong Ji, Dawei Zhang, Jing Xu et al. · Clinical Infectious Diseases · 2020 · 721 citations · Full text

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +16

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

Gregory Cheng, Mansoor N. Saleh, Claus Werenberg Marcher et al. · The Lancet · 2010 · 582 citations · Full text

Medicine, Hematology, Pharmacotherapy +7

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

James B. Bussel, Drew Provan, Tahir Shamsi et al. · The Lancet · 2009 · 539 citations

Medicine, Hematology, Pharmacotherapy +10